InsidersTradesSigma
Browse the complete record of transactions filed by Tardugno Michael H, Chairman & CEO. Director active across 1 companies, notably Celsion CORP. In total, 1 reports have been published. Total volume traded: €13k. The latest transaction was filed on 12 April 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Tardugno Michael H is the Chairman, President, and CEO of Celsion CORP, a biopharmaceutical company. He leads the company's operations and is responsible for overall strategy, focusing on the development of innovative cancer treatments.